Sana Biotechnology celebrated the beginning of a new chapter on its journey to make drugs that treat complicated diseases, cutting the ribbon outside the company’s new manufacturing facility in Bothell, Washington. Sana broke ground on the 80,000 square-foot facility one year ago after switching from a site in Fremont, Calif.
The Bothell facility will house Sana’s proprietary cancer drug program. The cell and gene therapy company plans to manufacture other drugs at the same site in the future.